UNSPSC 51192500: Combination prostaglandins

This classification denotes combination drugs and preparations in at least one constituient derives from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway, so called as PROSTA-GLANDINS or PROSTAGLANDINS because scientists first isolated and later synthesized these from the human prostate gland. Typical combination prostaglandin constituients are carboprost and tromethamine.

UNSPSC 51192500 Combination prostaglandins is a Class code covering pharmaceutical products that combine prostaglandin compounds for therapeutic use. State and local governments procure these medications through their health departments, corrections systems, public hospitals, and institutional healthcare facilities to serve inmate populations, indigent patients, and other state-managed clinical settings. The specific therapeutic applications and formulations vary by jurisdiction, but combination prostaglandins are typically stocked as part of standard pharmaceutical inventories in public healthcare systems.

The source provided contains no recent state or local contract opportunities tagged to this code and therefore offers no data on issuing-body mix, geographic concentration, or representative solicitations. Without posted procurement activity, no characterization of active buyer jurisdictions or regional concentration is possible.